Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (NYSE: EHAB), operating as Enhabit Home Health & Hospice, is a national home health and hospice provider whose activities generate a steady flow of company news and disclosures. As a public company listed on the New York Stock Exchange, Enhabit regularly issues press releases and files Form 8-K reports covering its financial results, strategic updates, leadership developments, and participation in investor conferences.
News about Enhabit often centers on quarterly earnings announcements, where the company reports net service revenue, segment performance for Home Health and Hospice, Adjusted EBITDA, and other financial and operational metrics. These releases highlight trends in home health and hospice admissions, average daily census, patient days, and segment-level profitability, as well as updates on branch openings, de novo locations, and changes in cost per patient day.
Investors following EHAB news will also see regular updates on guidance for net service revenue, Adjusted EBITDA, and Adjusted EPS, along with explanations of non-GAAP financial measures and same-store comparisons. Enhabit’s communications discuss how unusual or nonrecurring items affect its results and how management evaluates core operating performance.
Another key category of Enhabit news involves corporate and governance developments. The company has announced a CEO transition plan, retention awards for senior officers, approval of its 2025 Equity and Incentive Compensation Plan, and voting results from its annual meeting. In addition, Enhabit frequently reports on its participation in healthcare and home care conferences hosted by major financial institutions, where its leadership teams take part in fireside chats and presentations.
For readers tracking EHAB, this news flow provides insight into Enhabit’s home health and hospice operations, financial performance, capital structure, and governance decisions. Monitoring these updates can help contextualize the company’s strategic focus on patient care in the home and its reported progress across its nationwide footprint.
AREX Capital Management, LP, owning 4.9% of Enhabit, Inc. (NYSE: EHAB) shares, has issued an open letter urging fellow stockholders to support change at the upcoming Annual Meeting on July 25, 2024. AREX emphasizes that two leading proxy advisory firms have recommended stockholders support board changes. The investment firm criticizes Enhabit's historical excuses for poor performance and empty promises, highlighting the opportunity to add industry-specific expertise to the board.
AREX encourages stockholders to vote for all seven of its nominees on the WHITE Proxy Card, believing this will ensure Enhabit has a board with the right experience to oversee management and drive operational improvements. Stockholders can visit www.rehabEHAB.com for additional information and to download AREX's comprehensive turnaround plan presentation.
Enhabit (NYSE: EHAB) urges stockholders to vote FOR its nine nominees at the July 25 Annual Meeting to protect their investment value. The company highlights three consecutive quarters of strong operational results, including an expected Adjusted EBITDA of $24.5-$25.0 million and a $15 million debt reduction. Enhabit's Board emphasizes its fit-for-purpose composition with expertise in payors, hospital networks, and labor management.
The company criticizes AREX's proposed slate of directors for lacking relevant experience and warns that AREX's vague 'Five-Point Plan' and 'Transformation Committee' could derail Enhabit's progress. Enhabit recommends stockholders use the YELLOW proxy card to vote for its nominees, stressing the importance of maintaining momentum in its path to profitable growth.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, has released preliminary results for Q2 2024. Key highlights include:
- Adjusted EBITDA between $24.5 million and $25.0 million
- Bank debt reduced by $15 million, including a $10 million payment on the revolving credit facility
- 43% of non-Medicare visits now under payor innovation contracts at improved rates, up from 38% in Q1 2024
- Home health admissions increased 6.4% year-over-year, driven by non-Medicare admissions
- Hospice segment achieved monthly sequential growth in average daily census for the fifth consecutive month
The company reports continued business stabilization and positioning for profitable growth.
AREX Capital Management, owning 4.9% of Enhabit (NYSE: EHAB), announced that Institutional Shareholder Services Inc. (ISS) supports their call for boardroom change. ISS recommends Enhabit's stockholders elect three AREX nominees—Anna-Gene O'Neal, Mark W. Ohlendorf, and Dr. Gregory S. Sheff—at the 2024 Annual Meeting on July 25, 2024.
ISS cites Enhabit's lack of expertise in home health, hospice, and financial reporting. They highlight Enhabit's underperformance, with a 40% drop in adjusted EBITDA and significant TSR underperformance since the spin-off. AREX argues their nominees bring essential industry-specific expertise and operational oversight needed for Enhabit's turnaround.
Enhabit Home Health & Hospice (NYSE: EHAB) announced that Institutional Shareholder Services (ISS) has recommended stockholders vote in favor of a majority of Enhabit’s director nominees at the upcoming Annual Meeting on July 25, 2024. ISS recognizes the company’s promising performance in the last two quarters and its responsiveness to investor input, including adding new directors and running a public sales process. However, ISS suggests additional industry-relevant expertise might be beneficial.
Enhabit urges stockholders to support all nine of its nominees, highlighting their expertise and value in driving stockholder value. Disagreement exists over the exclusion of nominees Gregory Rush, Erin Hoeflinger, and Susan La Monica, whom Enhabit believes are important for their financial, payor industry, and human resources expertise, respectively. Stockholders are encouraged to vote using the YELLOW proxy card for the company's recommended nominees.
Enhabit (NYSE: EHAB), a leading national provider in home health and hospice care, announced its plans to report second-quarter results for the period ending June 30, 2024, on August 6, 2024. The company will also host a webcast and conference call on August 7, 2024, at 10 a.m. EDT. Stakeholders interested in participating should join the call 15 minutes early. Access details include a toll-free number (888-660-6150), an international line (929-203-0843), and a Conference ID (5248158). The webcast will be available on the Enhabit investor website, with online replay options provided. Enhabit operates 255 home health locations and 112 hospice locations across 34 states, leveraging advanced technology and compassionate care.
Enhabit, a major provider of home health and hospice services, has communicated with its stockholders ahead of the 2024 Annual Meeting, urging them to support its current Board of Directors. The company contends that AREX Capital Management's attempt to replace most of Enhabit's independent directors with less experienced candidates could destabilize the business. Enhabit highlights the extensive and relevant industry experience of its own board nominees, asserting that none of AREX's candidates possess the necessary expertise. The letter also refutes AREX's claims about Enhabit's business performance and cost management, emphasizing the company's recent achievements in stabilizing operations and positioning for growth. The Board critiques AREX's proposed 'Transformation Committee,' arguing it to be composed of inadequately qualified individuals. Enhabit concludes by urging stockholders to vote for its nominated directors using the enclosed YELLOW proxy card.
AREX Capital Management, owner of 4.9% of Enhabit’s shares, has expressed disappointment in Enhabit's recent investor presentation, accusing the company of recycling excuses and making unfulfilled promises. AREX believes Enhabit's strategies are failing, and emphasizes the company's lack of industry-specific expertise on its board. AREX urges shareholders to support its seven nominees for the board at the 2024 Annual Meeting, advocating for their plan to improve Enhabit's operational performance and create shareholder value.
Enhabit, a top home health and hospice provider, has shared an investor presentation ahead of its 2024 Annual Meeting on July 25. The company has shown improved performance, with a 5.3% increase in Home Health admissions and 5.6% growth in Hospice admissions. Non-Medicare admissions rose 25%, and payor innovation contracts now cover 38% of non-Medicare visits. Enhabit has added 151 full-time nurses. The Board, refreshed since the spin-off from Encompass Health, emphasizes its strategic initiatives and opposes AREX Capital's attempt to take control, citing it would disrupt business stability. Stockholders are urged to vote for Enhabit's nominees via the YELLOW proxy card.
AREX Capital Management, LP, which owns 4.9% of Enhabit’s outstanding common shares, has released a presentation outlining a comprehensive plan to improve Enhabit’s operational performance.
The plan includes recapturing home health market share, revamping hospice sales, and reducing corporate overhead, with an anticipated 50% increase in EBITDA. AREX is urging stockholders to vote for its seven nominees using the WHITE Proxy Card at the 2024 Annual Meeting.
AREX believes their nominees possess the necessary experience and skills to oversee management and drive significant value creation for Enhabit’s stockholders.
Further details are available at www.RehabEHAB.com.